An in vivo pharmacological evaluation of pardoprunox (SLV308) - A novel combined dopamine D-2/D-3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease

C. A. Jones, L. C. Johnston, M. J. Jackson, L. A. Smith, G. van Scharrenburg, S. Rose, P. G. Jenner, A. C. McCreary

Research output: Contribution to journal › Article › peer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'An in vivo pharmacological evaluation of pardoprunox (SLV308) - A novel combined dopamine D-2/D-3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science